Reflecting on Thirty Years of Experience With Active Surveillance for Papillary Thyroid Microcarcinoma.
作者信息
Mulder Michelle B, Duh Quan-Yang
机构信息
Section of Endocrine Surgery, UCSF Helen Diller Family Comprehensive Cancer Center, University of California, San Francisco, CA 94115, USA.
出版信息
J Endocr Soc. 2023 Aug 9;7(9):bvad105. doi: 10.1210/jendso/bvad105. eCollection 2023 Aug 2.
Abstract
摘要
相似文献
1
Reflecting on Thirty Years of Experience With Active Surveillance for Papillary Thyroid Microcarcinoma.回顾甲状腺微小乳头状癌主动监测30年的经验
J Endocr Soc. 2023 Aug 9;7(9):bvad105. doi: 10.1210/jendso/bvad105. eCollection 2023 Aug 2.
2
Active Surveillance of Low-Risk Papillary Microcarcinoma of the Thyroid: Kuma Hospital Protocol and Its Outcomes.甲状腺低风险乳头状微小癌的主动监测：熊本医院方案及其结果
VideoEndocrinology. 2016 Sep 14;3(3). doi: 10.1089/ve.2016.0073. eCollection 2016.
3
Surgery alone for papillary thyroid microcarcinoma is less costly and more effective than long term active surveillance.手术单独治疗甲状腺微小乳头状癌的成本更低，效果优于长期主动监测。
Surgery. 2020 Jan;167(1):110-116. doi: 10.1016/j.surg.2019.05.078. Epub 2019 Sep 19.
4
Contrastive study of two screening criteria for active surveillance in patients with low-risk papillary thyroid microcarcinoma: a retrospective analysis of 1001 patients.低危甲状腺微小乳头状癌患者主动监测两种筛查标准的对比研究：1001例患者的回顾性分析
Oncotarget. 2017 Jul 22;8(39):65836-65846. doi: 10.18632/oncotarget.19503. eCollection 2017 Sep 12.
5
[Retrospective comparison of screening criteria for active surveillance for papillary thyroid microcarcinoma].[甲状腺微小乳头状癌主动监测筛查标准的回顾性比较]
Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2017 Jun 7;52(6):430-434. doi: 10.3760/cma.j.issn.1673-0860.2017.06.007.
6
Conservative Surveillance Management of Low-Risk Papillary Thyroid Microcarcinoma.低危甲状腺微小乳头状癌的保守监测管理。
Endocrinol Metab Clin North Am. 2019 Mar;48(1):215-226. doi: 10.1016/j.ecl.2018.10.007. Epub 2018 Dec 23.
7
Insights into the Management of Papillary Microcarcinoma of the Thyroid.甲状腺微小乳头状癌的处理要点。
Thyroid. 2018 Jan;28(1):23-31. doi: 10.1089/thy.2017.0227. Epub 2017 Sep 22.
8
Preoperative and Postoperative Risk Stratification of Thyroid Papillary Microcarcinoma: A Comparative Study Between Kuma Criteria and 2015 American Thyroid Association Guidelines Risk Stratification.甲状腺乳头状微小癌的术前和术后风险分层：熊本标准与 2015 年美国甲状腺协会指南风险分层的比较研究。
Thyroid. 2020 Jun;30(6):857-862. doi: 10.1089/thy.2019.0698. Epub 2020 Mar 11.
9
Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma.主动监测可能是甲状腺微小乳头状癌的最佳初始治疗方法。
J Endocr Soc. 2023 May 16;7(7):bvad063. doi: 10.1210/jendso/bvad063. eCollection 2023 Jun 5.
10
Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.低危甲状腺微小乳头状癌：主动监测试验的回顾。
Eur J Surg Oncol. 2018 Mar;44(3):307-315. doi: 10.1016/j.ejso.2017.03.004. Epub 2017 Mar 16.
本文引用的文献
1
Active Surveillance May Be the Best Initial Management for Papillary Thyroid Microcarcinoma.主动监测可能是甲状腺微小乳头状癌的最佳初始治疗方法。
J Endocr Soc. 2023 May 16;7(7):bvad063. doi: 10.1210/jendso/bvad063. eCollection 2023 Jun 5.
2
Active Surveillance Versus Thyroid Surgery for Differentiated Thyroid Cancer: A Systematic Review.主动监测与甲状腺手术治疗分化型甲状腺癌：系统评价。
Thyroid. 2022 Apr;32(4):351-367. doi: 10.1089/thy.2021.0539. Epub 2022 Mar 17.
3
NATIONAL SURVEY OF ENDOCRINOLOGISTS AND SURGEONS REGARDING ACTIVE SURVEILLANCE FOR LOW-RISK PAPILLARY THYROID CANCER.全国内分泌学家和外科医生关于低危甲状腺乳头状癌主动监测的调查。
Endocr Pract. 2021 Jan;27(1):1-7. doi: 10.1016/j.eprac.2020.11.003. Epub 2020 Nov 17.
4
Physician Confidence in Neck Ultrasonography for Surveillance of Differentiated Thyroid Cancer Recurrence.医生对颈部超声检查监测分化型甲状腺癌复发的信心。
JAMA Otolaryngol Head Neck Surg. 2020 Dec 23;147(2):166-72. doi: 10.1001/jamaoto.2020.4471.
5
Trends in the Endocrinology Fellowship Recruitment: Reasons for Concern and Possible Interventions.内分泌学住院医师培训招募趋势：令人担忧的原因及可能的干预措施。
J Clin Endocrinol Metab. 2020 Jun 1;105(6):1701-6. doi: 10.1210/clinem/dgaa134.
6
Cost-effectiveness of active surveillance versus hemithyroidectomy for micropapillary thyroid cancer.微小乳头状甲状腺癌主动监测与甲状腺半切术的成本效益分析
Surgery. 2017 Jan;161(1):116-126. doi: 10.1016/j.surg.2016.06.076. Epub 2016 Nov 10.
7
Patients' Perspectives on Wait Times and the Referral-Consultation Process While Attending a Tertiary Diabetes and Endocrinology Centre: Is Econsultation an Acceptable Option?患者在 tertiary diabetes and endocrinology centre 就诊时对等候时间和转诊咨询流程的看法：电子咨询是否是一种可接受的选择？
Can J Diabetes. 2015 Aug;39(4):325-9. doi: 10.1016/j.jcjd.2014.12.010. Epub 2015 Mar 19.
8
An observational trial for papillary thyroid microcarcinoma in Japanese patients.日本患者甲状腺微小乳头状癌的观察性研究。
World J Surg. 2010 Jan;34(1):28-35. doi: 10.1007/s00268-009-0303-0.
Zotero 插件